Trevi Therapeutics TRVI Balance Sheet (2018-2026)

NASDAQ TRVI
$17.26 +0.20 (+1.20%)
As of: Sep 4, 2026 · 3:59 PM EDT
Reported Financials

Trevi Therapeutics Quarterly Balance Sheet

Periods 34 quarters
Latest Jun 2026

Trevi Therapeutics reported total assets of $330.52M and total liabilities of $9.01M for the quarter ended Jun 2026, up 58.6% year over year. This balance sheet covers 34 quarters of results from Mar 2018 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Balance Sheet Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Accumulated Depreciation
0.18M0.23M0.13M0.23M0.36M
Assets
Current Assets
Cash & EquivalentsCash & Equiv.
29.32M36.83M29.11M24.70M66.57M12.59M11.65M13.75M25.96M32.40M13.81M12.96M16.05M34.10M19.37M117.06M56.87M18.91M19.41M54.30M
Prepaid Assets
1.39M0.89M0.48M1.65M1.29M1.31M1.61M2.98M4.04M3.62M3.23M1.80M1.18M0.94M1.53M1.77M2.00M2.13M2.22M4.26M
Current Assets
30.71M37.96M29.84M79.89M127.32M122.62M114.20M99.21M93.95M87.55M76.77M72.13M67.34M109.43M105.62M207.23M198.30M191.66M176.12M325.70M
Non-Current Assets
Property, Plant & Equipment (Net)
0.07M0.05M0.04M0.03M0.07M0.17M0.24M0.23M0.24M0.22M0.20M0.20M0.17M0.16M0.28M0.24M0.21M0.18M0.27M0.34M
Long-Term Investments
1.00M
Other Non-Current Assets
0.33M0.40M0.41M0.92M0.20M0.23M0.07M0.30M0.30M0.31M0.27M0.26M0.24M0.24M0.07M0.10M0.93M2.61M3.94M
Non-Current Assets
0.89M0.52M0.55M1.53M1.04M0.40M2.00M1.76M1.94M1.86M1.79M1.68M1.57M1.47M1.38M1.11M1.06M1.78M3.48M4.81M
Assets
31.60M38.48M30.39M81.41M128.36M123.02M116.20M100.98M95.90M89.40M78.56M73.81M68.91M110.90M107.00M208.34M199.36M193.44M179.61M330.52M
Liabilities
Current Liabilities
Accounts Payables
2.23M2.85M1.74M3.94M2.33M2.86M1.98M1.35M1.26M1.81M2.11M1.51M1.61M3.41M1.42M2.97M2.71M3.91M2.21M3.10M
Payables
2.23M2.85M1.74M3.94M2.33M2.86M1.98M1.35M1.26M1.81M2.11M1.51M1.61M3.41M1.42M2.97M2.71M3.91M2.21M3.10M
Accumulated Expenses
3.31M3.81M3.88M4.40M5.25M3.52M3.47M3.08M3.62M3.71M2.84M4.93M7.21M6.81M5.17M5.98M6.04M5.53M4.58M5.31M
Other Accumulated Expenses
0.07M0.08M0.08M0.33M0.41M0.50M0.47M0.05M0.07M0.01M0.06M0.04M0.04M0.04M0.09M0.01M0.13M0.18M0.12M0.13M
Short term Debt
4.08M5.83M7.00M7.00M7.00M7.00M7.48M
Current Leases
0.12M0.12M0.12M0.09M0.06M0.03M0.14M0.16M0.17M0.18M0.20M0.22M0.23M0.25M0.28M0.29M0.30M0.31M0.32M0.33M
Total Current Liabilities
9.91M12.72M12.87M15.43M14.64M13.40M13.20M4.71M5.17M5.82M5.28M6.75M9.12M10.51M6.87M9.24M9.04M9.75M7.12M8.74M
Non-Current Liabilities
Capital Leases
0.12M0.09M0.06M0.03M
Non-Current Debt
10.24M8.65M7.06M5.43M3.80M2.15M
Non-Current Deffered Revenue
0.42M
Preferred Stock Liabilities
Operating Leases
0.06M0.02M0.00M0.00M0.00M1.15M1.10M1.05M1.00M0.95M0.88M0.82M0.75M0.68M0.60M0.53M0.45M0.36M0.28M
Other Non-Current Liabilities
0.17M0.11M0.12M0.04M0.01M0.00M
Total Non-Current Liabilities
20.05M21.29M19.80M20.86M18.44M15.55M
Total Liabilities
20.22M21.40M19.92M20.90M18.46M15.56M14.47M5.90M6.29M6.86M6.22M7.64M9.94M11.26M7.55M9.85M9.57M10.20M7.48M9.01M
Shareholder's Equity
Total Debt
14.33M14.48M14.06M12.43M10.80M9.15M7.48M
Common Equity
11.38M17.07M10.46M60.52M109.90M107.46M101.73M95.07M89.61M82.55M72.33M66.17M58.97M99.64M99.46M198.49M189.79M183.24M172.13M321.51M
Liabilities and Shareholders Equity
31.60M38.48M30.39M81.41M128.36M123.02M116.20M100.98M95.90M89.40M78.56M73.81M68.91M110.90M107.00M208.34M199.36M193.44M179.61M330.52M
Retained Earnings
183.75M197.96M198.68M256.91M314.67M317.59M318.23M318.87M321.08M321.64M322.37M328.57M334.38M386.53M396.67M508.03M511.12M512.77M515.18M682.58M
Preferred Shares
Treasury Shares